|
[1]
|
Rapport, M.M., Green, A.A. and Page, I.H. (1948) Serum Vasoconstrictor, Serotonin; Isolation and Characterization. The Journal of Biological Chemistry, 176, 1243-1251. [Google Scholar] [CrossRef]
|
|
[2]
|
Ber-ger, M., Gray, J.A. and Roth, B.L. (2009) The Expanded Biology of Serotonin. Annual Review of Medicine, 60, 355-366. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Khan, W.I. and Ghia, J.E. (2010) Gut Hormones: Emerging Role in Immune Activation and Inflammation. Clinical and Experimental Immunology, 161, 19-27. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Walther, D.J., Peter, J.U., Bashammakh, S., et al. (2003) Synthesis of Serotonin by a Second Tryptophan Hydroxylase Isoform. Science, 299, 76. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Zhang, X., Beaulieu, J.M., Sotnikova, T.D., et al. (2004) Tryptophan Hydroxylase-2 Controls Brain Serotonin Synthesis. Science, 305, 217. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Côté, F., Thévenot, E., Fligny, C., et al. (2003) Disruption of the Nonneuronal tph1 Gene Demonstrates the Importance of Peripheral Serotonin in Cardiac Function. Proceedings of the National Academy of Sciences of the United States of America, 100, 13525-13530. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Yabut, J.M., Crane, J.D., Green, A.E., et al. (2019) Emerging Roles for Serotonin in Regulating Metabolism: New Implications for an Ancient Molecule. Endocrine Reviews, 40, 1092-1107. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Fitzpatrick, P.F. (1999) Tetrahydropterin-Dependent Amino Acid Hydroxylases. Annual Review of Biochemistry, 68, 355-381. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Walther, D.J., Peter, J.U., Winter, S., et al. (2003) Seroto-nylation of Small GTPases Is a Signal Transduction Pathway that Triggers Platelet Alpha-Granule Release. Cell, 115, 851-862. [Google Scholar] [CrossRef]
|
|
[10]
|
Nichols, D.E. and Nichols, C.D. (2008) Serotonin Receptors. Chemical Reviews, 108, 1614-1641. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
King, M.V., Marsden, C.A. and Fone, K.C. (2008) A Role for the 5-HT(1A), 5-HT4 and 5-HT6 Receptors in Learning and Memory. Trends in Pharmacological Sciences, 29, 482-492. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Eglen, R.M., Wong, E.H., Dumuis, A., et al. (1995) Central 5-HT4 Receptors. Trends in Pharmacological Sciences, 16, 391-398. [Google Scholar] [CrossRef]
|
|
[13]
|
Cortes-Altamirano, J.L., Olmos-Hernandez, A., Jaime, H.B., et al. (2018) Review: 5-HT1, 5-HT2, 5-HT3 and 5-HT7 Receptors and Their Role in the Modulation of Pain Response in the Central Nervous System. Current Neuropharmacology, 16, 210-221. [Google Scholar] [CrossRef]
|
|
[14]
|
Sah, V.P., Seasholtz, T.M., Sagi, S.A., et al. (2000) The Role of Rho in G Protein-Coupled Receptor Signal Transduction. Annual Review of Pharmacology and Toxicology, 40, 459-489. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Barnes, N.M., Hales, T.G., Lummis, S.C., et al. (2009) The 5-HT3 Receptor—The Relationship between Structure and Function. Neuropharmacology, 56, 273-284. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Machu, T.K. (2011) Therapeutics of 5-HT3 Receptor An-tagonists: Current Uses and Future Directions. Pharmacology & Therapeutics, 130, 338-347. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Evans, R.M., Barish, G.D. and Wang, Y.X. (2004) PPARs and the Complex Journey to Obesity. Nature Medicine, 10, 355-361. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Lehrke, M. and LAZAR, M.A. (2005) The Many Faces of PPARgamma. Cell, 123, 993-999. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Mckenna, N.J., Cooney, A.J., Demayo, F.J., et al. (2009) Mini-review: Evolution of NURSA, the Nuclear Receptor Signaling Atlas. Molecular Endocrinology, 23, 740-746. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Odegaard, J.I., Ricardo-Gonzalez, R.R., Goforth, M.H., et al. (2007) Macrophage-Specific PPARgamma Controls Alternative Activation and Improves Insulin Resistance. Nature, 447, 1116-1120. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Walczak, R. and Tontonoz, P. (2002) PPARadigms and PPARadoxes: Expanding roles for PPARgamma in the Control of Lipid Metabolism. Journal of Lipid Research, 43, 177-186. [Google Scholar] [CrossRef]
|
|
[22]
|
Hirai, H., Tanaka, K., Takano, S., et al. (2002) Cutting Edge: Agonistic Effect of Indomethacin on a Prostaglandin D2 Receptor, CRTH2. Journal of Immunology, 168, 981-985. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Waku, T., Shiraki, T., Oyama, T., et al. (2010) The Nu-clear Receptor PPARγ Individually Responds to Serotonin- and Fatty Acid-Metabolites. The EMBO Journal, 29, 3395-3407. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Skurk, T., Alberti-Huber, C., Herder, C., et al. (2007) Relationship between Adipocyte Size and Adipokine Expression and Secretion. The Journal of Clinical Endocrinology and Metabolism, 92, 1023-1033. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Benrick, A., Chanclón, B., Micallef, P., et al. (2017) Adiponectin Pro-tects against Development of Metabolic Disturbances in a PCOS Mouse Model. Proceedings of the National Academy of Sciences of the United States of America, 114, E7187-E7196. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Ro-sene, D. and Spiegelman, B.M. (2014) What We Talk about When We Talk about Fat. Cell, 156, 20-44. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Zhao, G.N., Tian, Z.W., Tian, T., et al. (2021) TMBIM1 is an In-hibitor of Adipogenesis and Its Depletion Promotes Adipocyte Hyperplasia and Improves Obesity-Related Metabolic Disease. Cell Metabolism, 33, 1640-1654.E8. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Foti, M., Porcheron, G., Fournier, M., et al. (2007) The Neck of Caveolae Is a Distinct Plasma Membrane Subdomain that Concentrates Insulin Receptors in 3T3-L1 Adipocytes. Pro-ceedings of the National Academy of Sciences of the United States of America, 104, 1242-1247. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Reed, B.C., Kaufmann, S.H., Mackall, J.C., et al. (1977) Altera-tions in Insulin Binding Accompanying Differentiation of 3T3-L1 Preadipocytes. Proceedings of the National Academy of Sciences of the United States of America, 74, 4876-4880. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
KOHLER, H.P. and GRANT, P.J. (2000) Plasminogen-Activator Inhibitor type 1 and Coronary Artery Disease. The New England Journal of Medicine, 342, 1792-1801. [Google Scholar] [CrossRef]
|
|
[31]
|
Eriksson, P., Reynisdottir, S., Lönnqvist, F., et al. (1998) Adipose Tissue Secretion of Plasminogen Activator Inhibitor-1 in Non-Obese and Obese Individuals. Diabetologia, 41, 65-71. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Yamauchi, T., Kamon, J., Ito, Y., et al. (2003) Cloning of Adiponectin Receptors that Mediate Antidiabetic Metabolic Effects. Nature, 423, 762-769. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Uchida-Kitajima, S., Yamauchi, T., Takashina, Y., et al. (2008) 5-Hydroxytryptamine 2A Receptor Signaling Cascade Modulates Adiponectin and Plasminogen Activator Inhibitor 1 Expression in Adipose Tissue. FEBS Letters, 582, 3037-3044. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Kinoshita, M., Ono, K., Horie, T., et al. (2010) Regulation of Adipocyte Differentiation by Activation of Serotonin (5-HT) Receptors 5-HT2AR and 5-HT2CR and Involvement of MicroRNA-448-Mediated Repression of KLF5. Molecular Endocrinology, 24, 1978-1987. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Kim, S.P., Ha, J.M., Yun, S.J., et al. (2010) Transcriptional Activation of Peroxisome Proliferator-Activated Receptor-Gamma Requires Activation of Both Protein Kinase A and Akt during Adipocyte Differentiation. Biochemical and Biophysical Research Communications, 399, 55-59. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Yun, J., Jin, H., Cao, Y., et al. (2018) RNA-Seq Analysis Reveals a Positive Role of HTR2A in Adipogenesis in Yan Yellow Cattle. International Journal of Molecular Sciences, 19, Arti-cle No. 1760. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Peng, X.D., Xu, P.Z., Chen, M.L., et al. (2003) Dwarfism, Impaired Skin Development, Skeletal Muscle Atrophy, Delayed Bone Development, and Impeded Adipogenesis in Mice Lacking Akt1 and Akt2. Genes & Development, 17, 1352-1365. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Mota de Sá, P., Richard, A.J., Hang, H., et al. (2017) Transcriptional Regulation of Adipogenesis. Comprehensive Physiology, 7, 635-674. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Yang, M., Sun, J., Zhang, T., et al. (2008) Deficiency and In-hibition of Cathepsin K Reduce Body Weight Gain and Increase Glucose Metabolism in Mice. Arteriosclerosis, Throm-bosis, and Vascular Biology, 28, 2202-2208. [Google Scholar] [CrossRef]
|
|
[40]
|
Söhle, J., Machuy, N., Smailbegovic, E., et al. (2012) Iden-tification of New Genes Involved in Human Adipogenesis and Fat Storage. PLoS ONE, 7, e31193. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Lin, Y., Bao, B., Yin, H., et al. (2019) Peripheral Cathepsin L Inhibition Induces Fat Loss in C. Elegans and Mice through Promoting Central Serotonin Synthesis. BMC Biology, 17, Article No. 93. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Cannon, B. and Nedergaard, J. (2004) Brown Adipose Tissue: Function and Physiological Significance. Physiological Reviews, 84, 277-359. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Kajimura, S., Seale, P. and Spiegelman, B.M. (2010) Transcrip-tional Control of Brown Fat Development. Cell Metabolism, 11, 257-262. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Bargut, T.C., Aguila, M.B. and Mandarim-DE-Lacerda, C.A. (2016) Brown Adipose Tissue: Updates in Cellular and Molecular Biology. Tissue & Cell, 48, 452-460. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Harms, M. and Seale, P. (2013) Brown and Beige Fat: Develop-ment, Function and Therapeutic Potential. Nature Medicine, 19, 1252-1263. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Kajimura, S. and Saito, M. (2014) A New Era in Brown Adipose Tissue Bi-ology: Molecular Control of Brown Fat Development and Energy Homeostasis. Annual Review of Physiology, 76, 225-249. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Oh, C.M., Park, S. and Kim, H. (2016) Serotonin as a New Therapeutic Target for Diabetes Mellitus and Obesity. Diabetes & Metabolism Journal, 40, 89-98. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Jeong, J.H., Lee, D.K., Blouet, C., et al. (2015) Cholinergic Neu-rons in the Dorsomedial Hypothalamus Regulate Mouse Brown Adipose Tissue Metabolism. Molecular Metabolism, 4, 483-492. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Mcglashon, J.M., Gorecki, M.C., Kozlowski, A.E., et al. (2015) Central Serotonergic Neurons Activate and Recruit Thermogenic Brown and Beige Fat and Regulate Glucose and Lipid Homeostasis. Cell Metabolism, 21, 692-705. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Montanari, T., Pošćić, N. and Colitti, M. (2017) Factors Involved in White-to-Brown Adipose Tissue Conversion and in Thermogenesis: A Review. Obesity Reviews: An Official Journal of the International Association for the Study of Obesity, 18, 495-513. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Ni-soli, E. and Carruba, M.O. (2000) An Assessment of the Safety and Efficacy of Sibutramine, an Anti-Obesity Drug with a Novel Mechanism of Action. Obesity Reviews: An Official Journal of the International Association for the Study of Obesity, 1, 127-139. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Li, M.F. and Cheung, B.M. (2011) Rise and Fall of Anti-Obesity Drugs. World Journal of Diabetes, 2, 19-23. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Da Silva, A.I., Braz, G.R., Pedroza, A.A., et al. (2015) Fluoxetine In-duces Lean Phenotype in Rat by Increasing the Brown/White Adipose Tissue Ratio and UCP1 Expression. Journal of Bioenergetics and Biomembranes, 47, 309-318. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Crane, J.D., Palanivel, R., Mottillo, E.P., et al. (2015) Inhibiting Peripheral Serotonin Synthesis Reduces Obesity and Metabolic Dysfunction by Promoting Brown Adipose Tissue Thermogenesis. Nature Medicine, 21, 166-172. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
Wu, J., Boström, P., Sparks, L.M., et al. (2012) Beige Adipocytes Are a Distinct Type of Thermogenic Fat Cell in Mouse and Human. Cell, 150, 366-376. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Garcia, R.A., Roemmich, J.N. and Claycombe, K.J. (2016) Evalua-tion of Markers of Beige Adipocytes in White Adipose Tissue of the Mouse. Nutrition & Metabolism, 13, Article No. 24. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Steinberg, G.R. (2018) Cellular Energy Sensing and Metabo-lism-Implications for Treating Diabetes: The 2017 Outstanding Scientific Achievement Award Lecture. Diabetes, 67, 169-179. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
Nakamura, K. and Morrison, S.F. (2011) Central Efferent Pathways for Cold-Defensive and Febrile Shivering. The Journal of Physiology, 589, 3641-3658. [Google Scholar] [CrossRef] [PubMed]
|
|
[59]
|
Nakamura, K., Matsumura, K., Hübschle, T., et al. (2004) Iden-tification of Sympathetic Premotor Neurons in Medullary Raphe Regions Mediating Fever and Other Thermoregulatory Functions. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 24, 5370-5380. [Google Scholar] [CrossRef]
|
|
[60]
|
O’Neil, P.M., Smith, S.R., Weissman, N.J., et al. (2012) Randomized Placebo-Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM-DM Study. Obesity, 20, 1426-1436. [Google Scholar] [CrossRef] [PubMed]
|
|
[61]
|
Krashes, M.J., Koda, S., Ye, C., et al. (2011) Rapid, Reversible Activa-tion of AgRP Neurons Drives Feeding Behavior in Mice. The Journal of Clinical Investigation, 121, 1424-1428. [Google Scholar] [CrossRef]
|
|
[62]
|
Small, C.J., Liu, Y.L., Stanley, S.A., et al. (2003) Chronic CNS Admin-istration of Agouti-Related Protein (Agrp) Reduces Energy Expenditure. International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity, 27, 530-533. [Google Scholar] [CrossRef] [PubMed]
|
|
[63]
|
Ruan, H.B., Dietrich, M.O., Liu, Z.W., et al. (2014) O-GlcNAc Trans-ferase Enables AgRP Neurons to Suppress Browning of White Fat. Cell, 159, 306-317. [Google Scholar] [CrossRef] [PubMed]
|
|
[64]
|
Burke, L.K., Darwish, T., Cavanaugh, A.R., et al. (2017) mTORC1 in AGRP Neurons Integrates Exteroceptive and Interoceptive Food-Related Cues in the Modulation of Adaptive Energy Expenditure in Mice. eLife, 6, e22848.
|
|
[65]
|
Deng, J., Yuan, F., Guo, Y., et al. (2017) Deletion of ATF4 in AgRP Neu-rons Promotes Fat Loss Mainly via Increasing Energy Expenditure. Diabetes, 66, 640-650. [Google Scholar] [CrossRef] [PubMed]
|
|
[66]
|
Dodd, G.T., Andrews, Z.B., Simonds, S.E., et al. (2017) A Hypothalamic Phosphatase Switch Coordinates Energy Expenditure with Feeding. Cell Metabolism, 26, 375-393.E7. [Google Scholar] [CrossRef] [PubMed]
|
|
[67]
|
Berglund, E.D., Liu, C., Sohn, J.W., et al. (2013) Serotonin 2C Receptors in Pro-Opiomelanocortin Neurons Regulate Energy and Glucose Homeostasis. The Journal of Clinical Inves-tigation, 123, 5061-5070. [Google Scholar] [CrossRef]
|
|
[68]
|
Zhang, X., Wang, X., Yin, H., et al. (2019) Functional Inactivation of Mast Cells Enhances Subcutaneous Adipose Tissue Browning in Mice. Cell Reports, 28, 792-803.E4. [Google Scholar] [CrossRef] [PubMed]
|
|
[69]
|
Lim, S., Honek, J., Xue, Y., et al. (2012) Cold-Induced Activa-tion of Brown Adipose Tissue and Adipose Angiogenesis in Mice. Nature protocols, 7, 606-615. [Google Scholar] [CrossRef] [PubMed]
|
|
[70]
|
Lee, Y.H., Petkova, A.P., Mottillo, E.P., et al. (2012) In Vivo Identi-fication of Bipotential Adipocyte Progenitors Recruited by β3-Adrenoceptor Activation and High-Fat Feeding. Cell Me-tabolism, 15, 480-491. [Google Scholar] [CrossRef] [PubMed]
|
|
[71]
|
Roh, H.C., Tsai, L.T.Y., Shao, M., et al. (2018) Warming Induces Significant Reprogramming of Beige, but Not Brown, Adipocyte Cellular Identity. Cell Metabolism, 27, 1121-1137.E5. [Google Scholar] [CrossRef] [PubMed]
|
|
[72]
|
Hellman, B., Larsson, S. and Westman, S. (1963) Mast Cell Con-tent and fatty Acid Metabolism in the Epididymal Fat Pad of Obese Mice. Acta Physiologica Scandinavica, 58, 255-262. [Google Scholar] [CrossRef] [PubMed]
|
|
[73]
|
Divoux, A., Moutel, S., Poitou, C., et al. (2012) Mast Cells in Human Adipose Tissue: Link with Morbid Obesity, Inflammatory Status, and Diabetes. The Journal of Clinical Endocrinology and Metabolism, 97, E1677-E1685. [Google Scholar] [CrossRef] [PubMed]
|
|
[74]
|
Oh, C.M., Namkung, J., Go, Y., et al. (2015) Regulation of Systemic Energy Homeostasis by Serotonin in Adipose Tissues. Nature Communications, 6, Article No. 6794. [Google Scholar] [CrossRef] [PubMed]
|
|
[75]
|
Yabut, J.M., Desjardins, E.M., Chan, E.J., et al. (2020) Genetic Dele-tion of Mast Cell Serotonin Synthesis Prevents the Development of Obesity and Insulin Resistance. Nature Communica-tions, 11, Article No. 463. [Google Scholar] [CrossRef] [PubMed]
|
|
[76]
|
Younossi, Z., Anstee, Q.M., Marietti, M., et al. (2018) Global Burden of NAFLD and NASH: Trends, Predictions, Risk Factors and Prevention. Nature Reviews Gastroenterology & Hepatology, 15, 11-20. [Google Scholar] [CrossRef] [PubMed]
|
|
[77]
|
Musso, G., Gambino, R. and Cassader, M. (2009) Recent Insights into Hepatic Lipid Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD). Progress in Lipid Research, 48, 1-26. [Google Scholar] [CrossRef] [PubMed]
|
|
[78]
|
Pais, R., Barritt, A.S.T., Calmus, Y., et al. (2016) NAFLD and Liver Transplantation: Current Burden and Expected Challenges. Journal of Hepatology, 65, 1245-1257. [Google Scholar] [CrossRef] [PubMed]
|
|
[79]
|
Michelotti, G.A., Machado, M.V. and Diehl, A.M. (2013) NAFLD, NASH and Liver Cancer. Nature Reviews Gastroenterology & Hepatology, 10, 656-665. [Google Scholar] [CrossRef] [PubMed]
|
|
[80]
|
Namkung, J., Shong, K.E., Kim, H., et al. (2018) Inhibition of Ser-otonin Synthesis Induces Negative Hepatic Lipid Balance. Diabetes & Metabolism Journal, 42, 233-243. [Google Scholar] [CrossRef] [PubMed]
|
|
[81]
|
Choi, W., Namkung, J., Hwang, I., et al. (2018) Serotonin Signals through a Gut-Liver Axis to Regulate Hepatic Steatosis. Nature Communications, 9, Article No. 4824. [Google Scholar] [CrossRef] [PubMed]
|
|
[82]
|
Osawa, Y., Kanamori, H., Seki, E., et al. (2011) L-tryptophan-Mediated Enhancement of Susceptibility to Nonalcoholic Fatty Liver Disease Is Dependent on the Mamma-lian Target of Rapamycin. The Journal of Biological Chemistry, 286, 34800-34808. [Google Scholar] [CrossRef]
|
|
[83]
|
Haub, S., Ritze, Y., Ladel, I., et al. (2011) Serotonin Receptor Type 3 Antagonists Improve Obesity-Associated Fatty Liver Disease in Mice. The Journal of Pharmacology and Experimental Therapeutics, 339, 790-798. [Google Scholar] [CrossRef] [PubMed]
|
|
[84]
|
Kim, M., Hwang, I., Pagire, H.S., et al. (2020) Design, Synthesis, and Biological Evaluation of New Peripheral 5HT(2A) Antagonists for Nonalcoholic Fatty Liver Disease. Journal of Medicinal Chemistry, 63, 4171-4182. [Google Scholar] [CrossRef] [PubMed]
|
|
[85]
|
Coates, M.D., Johnson, A.C., Greenwood-Van Meerveld, B., et al. (2006) Effects of Serotonin Transporter Inhibition on Gastrointestinal Motility and Colonic Sensitivity in the Mouse. Neurogastroenterology and Motility: The Official Journal of the European Gastrointestinal Motility Society, 18, 464-471. [Google Scholar] [CrossRef] [PubMed]
|